Predicting clinical decline and conversion to Alzheimer’s disease or dementia using novel Elecsys Aβ(1–42), pTau and tTau CSF immunoassays

We evaluated the performance of CSF biomarkers for predicting risk of clinical decline and conversion to dementia in non-demented patients with cognitive symptoms. CSF samples from patients in two multicentre longitudinal studies (ADNI, n = 619; BioFINDER, n = 431) were analysed. Aβ(1–42), tTau and...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Sci Rep
Autors principals: Blennow, Kaj, Shaw, Leslie M., Stomrud, Erik, Mattsson, Niklas, Toledo, Jon B., Buck, Katharina, Wahl, Simone, Eichenlaub, Udo, Lifke, Valeria, Simon, Maryline, Trojanowski, John Q., Hansson, Oskar
Format: Artigo
Idioma:Inglês
Publicat: Nature Publishing Group UK 2019
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6911086/
https://ncbi.nlm.nih.gov/pubmed/31836810
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54204-z
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars